Overview

Effect Of Meloxicam Versus Placebo In Mainland Chinese Patients With Osteoarthritis Of The Knee

Status:
Completed
Trial end date:
2013-03-27
Target enrollment:
Participant gender:
Summary
This study is to validate the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) tool in mainland Chinese patients with osteoarthritis of the knee . This study will also evaluate the effects of Mobic versus placebo on reducing the symptoms of osteoarthritis in this population.
Phase:
N/A
Details
Lead Sponsor:
Pfizer
Treatments:
Meloxicam